Prognostic Value of Tumor-Infiltrating Lymphocytes in Resected Pancreatic Ductal Adenocarcinoma: A Single-Center Retrospective Australian Study.

Cureus · 2026 · PMC12906252 · PMID 41694163

Europe PMC DOI

hedged sentence

0.0640

closest p · 1.3× alpha

0.0640

boldest claim

The sentences

did not reach statistical significancep = 0.064so close (0.05 < p ≤ 0.1)

Median CA19-9 levels decreased from 140 U/mL (range 28-1600) before neoadjuvant therapy to 34.5 U/mL (range 5-970) after therapy, although this did not reach statistical significance on paired Wilcoxon signed-rank testing (p = 0.064).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.